Stay updated on Belumosudil for Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Belumosudil for Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Belumosudil for Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check14 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.7%
- Check21 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check57 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed descriptions of a Phase 2 study for the drug belumosudil in treating Idiopathic Pulmonary Fibrosis (IPF), while retaining some key identifiers like the study name KD025-207 and the revision number.SummaryDifference31%
- Check64 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
Stay in the know with updates to Belumosudil for Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belumosudil for Idiopathic Pulmonary Fibrosis Clinical Trial page.